In terms of signaling, the APP/PS1 AD model shows reduced responsiveness to adrenergic agonists, although β1-adrenergic receptor expression is apparently unchanged in APP/PS1 hearts (Turdi et al., 2009). The gene discussed is APP; the disease is Alzheimer disease.